Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9X3Y

NPFF bound Mas1 Receptor

Summary for 9X3Y
Entry DOI10.2210/pdb9x3y/pdb
EMDB information66514
DescriptorProto-oncogene Mas, NPFF (2 entities in total)
Functional Keywordsgpcr, agonist, orphan receptor, peptide binding protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight38585.30
Authors
Zhang, Y.M.,Liu, H.,Xu, H.E. (deposition date: 2025-10-09, release date: 2026-04-15)
Primary citationZhang, Y.,Wang, Q.,Liu, H.,Shan, H.,Gu, Y.,Yang, J.,Gao, Y.,Wu, K.,Yang, D.,Xu, H.E.
Structural insight into ligand binding and activation of the orphan GPCR Mas1.
Embo J., 2026
Cited by
PubMed Abstract: The Mas1 receptor, an orphan class A G-protein-coupled receptor (GPCR), plays pivotal roles in cardiovascular and anti-inflammatory regulation. Despite its therapeutic relevance, the structural mechanisms underlying Mas1 ligand binding and activation remain poorly understood. Here, we report cryo-EM structures of Mas1 bound to two chemically distinct agonists-neuropeptide FF (NPFF) and synthetic small-molecule AR234958-captured in complex with inhibitory G proteins. These structures reveal a conserved orthosteric binding pocket accommodating both ligands through shared hydrophobic interactions. Unlike many other class A GPCRs that rely on direct W toggle switch engagement, Mas1 adopts a non-canonical activation strategy driven by a ligand-induced hydrophobic compression plane involving residues Y248, L87, I84, and L266 at the bottom of the ligand binding pocket. This mechanism transmits mechanical tension to promote TM6 displacement and G protein coupling. Functional mutagenesis validates this model, identifying two transmembrane helix 6 (TM6) residues, M244 and F237, as critical molecular switches. Comparative analyses of Mas1-related receptors, MRGPRX1-X4, reveal conserved features and mechanistic divergence within this subfamily. These findings provide a structural framework for understanding Mas1 pharmacology and rational design of selective therapeutics.
PubMed: 41912627
DOI: 10.1038/s44318-026-00764-6
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.77 Å)
Structure validation

252091

PDB entries from 2026-04-15

PDB statisticsPDBj update infoContact PDBjnumon